Literature DB >> 17911985

Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments.

Gürkan Kaya1, Jean-Hilaire Saurat.   

Abstract

BACKGROUND: Skin aging has long been considered only as a cosmetic problem. With the increase in lifespan, we are now more often experiencing a further dimension of skin aging, which is no longer only cosmetic, but also functional, in the sense that the skin has lost its protective mechanical function. Dermatoporosis is the name proposed to capture, in a holistic approach, all the aspects of this chronic cutaneous insufficiency/fragility syndrome. OBSERVATIONS: In this paper, we review the clinical aspects of dermatoporosis, its histological features and the current understanding of its etiological factors. The clinical manifestations of dermatoporosis comprise (i) morphological markers of fragility--rather trivial--such as senile purpura, stellate pseudoscars and skin atrophy, and (ii) functional expression of skin fragility resulting from minor traumas such as frequent skin laceration, delayed wound healing, nonhealing atrophic ulcers and subcutaneous bleeding with the formation of dissecting hematomas leading to large zones of necrosis. Dissecting hematomas bear significant morbidity needing hospitalization and urgent surgical procedures. Molecular mechanisms implying hyaluronate-CD44 pathways in the control and maintenance of epithelial growth and the viscoelastic properties of the extracellular matrix offer new opportunities for preventive intervention.
CONCLUSION: We propose to group the different manifestations and implications of this syndrome under the umbrella term of 'dermatoporosis', because we think it will help to capture the understanding of health professionals that, as osteoporosis, 'dermatoporosis' should be prevented and treated to avoid complications. Dermatologists should be aware of this emerging syndrome and function as key players in prevention and therapy. Randomized clinical trials should demonstrate which intervention may best prevent and/or reverse dermatoporosis. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17911985     DOI: 10.1159/000107621

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  33 in total

1.  Frailty and aging.

Authors:  S Sourdet; M E Rougé-Bugat; B Vellas; F Forette
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

2.  Mechanisms of skin aging induced by EGFR inhibitors.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Peter Hevezi; Edwin Bölke; Dennis Sohn; Reiner U Jänicke; Viswanath Reddy Belum; Caroline Robert; Mario E Lacouture; Bernhard Homey
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

3.  Exploring the prevalence of skin tears and skin properties related to skin tears in elderly patients at a long-term medical facility in Japan.

Authors:  Yuiko Koyano; Gojiro Nakagami; Shinji Iizaka; Takeo Minematsu; Hiroshi Noguchi; Nao Tamai; Yuko Mugita; Aya Kitamura; Keiko Tabata; Masatoshi Abe; Ryoko Murayama; Junko Sugama; Hiromi Sanada
Journal:  Int Wound J       Date:  2014-03-28       Impact factor: 3.315

Review 4.  Topical corticosteroid-induced skin atrophy: a comprehensive review.

Authors:  Laurent Barnes; Gurkan Kaya; Victoria Rollason
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

5.  Reversal of murine epidermal atrophy by topical modulation of calcium signaling.

Authors:  Basile Darbellay; Laurent Barnes; Wolf-Henning Boehncke; Jean-Hilaire Saurat; Gürkan Kaya
Journal:  J Invest Dermatol       Date:  2013-12-06       Impact factor: 8.551

6.  Skin property can predict the development of skin tears among elderly patients: a prospective cohort study.

Authors:  Yuiko Koyano; Gojiro Nakagami; Shinji Iizaka; Junko Sugama; Hiromi Sanada
Journal:  Int Wound J       Date:  2016-10-19       Impact factor: 3.315

Review 7.  [Dermatological symptoms in rheumatology].

Authors:  E Aberer
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 8.  Aquaporin-3 in the epidermis: more than skin deep.

Authors:  Wendy B Bollag; Lorry Aitkens; Joseph White; Kelly A Hyndman
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-08       Impact factor: 4.249

Review 9.  Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options.

Authors:  Hilde Beele; Steven Smet; Nele Van Damme; Dimitri Beeckman
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

Review 10.  Treatment of Actinic Purpura.

Authors:  Roger I Ceilley
Journal:  J Clin Aesthet Dermatol       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.